Influence of ultrasound contrast agents on spectral Doppler analysis in recipients of liver transplantation
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Clinical validation is required to determine whether Doppler measurements are comparable before and after administering ultrasound contrast agent (USCA). The purpose of this study is to explore whether the use of USCA affects spectral Doppler analysis in recipients of liver transplantation (LT). Methods: For this study, 36 patients were examined using Doppler ultrasonography (US) along with a contrast-enhanced US for surveillance of vascular complications after LT. The following spectral Doppler US parameters were measured before and after administration of USCA: peak systolic velocity, end-diastolic velocity, resistive index, and systolic acceleration time of the graft hepatic artery; peak flow velocity of the graft portal vein; and peak flow velocity and venous pulsatility index of the graft hepatic vein. Results: The mean peak systolic and end-diastolic velocities of the hepatic artery and the peak flow velocity of the portal and hepatic veins were increased after intravenously administration of the USCA, ranging from 10% to 13%. However, the changes were not statistically significant (P=0.097, 0.103, 0.128, and 0.190, respectively). There were no significant differences in other measured parameters, including the resistive index (P=0.205) and systolic acceleration time (P=0.489) of the hepatic artery and venous pulsatility index (P=0.494) of the hepatic vein. Conclusions: The measured velocities of graft hepatic vessels tended to increase after administration of USCA, but without statistical significance. The comparison of serial Doppler parameters with or without injection of USCA is valid during Doppler surveillance in recipients of LT.
Abstract
Background/Aims: Clinical validation is required to determine whether Doppler measurements are comparable before and after administering ultrasound contrast agent (USCA). The purpose of this study is to explore whether the use of USCA affects spectral Doppler analysis in recipients of liver transplantation (LT). Methods: For this study, 36 patients were examined using Doppler ultrasonography (US) along with a contrast-enhanced US for surveillance of vascular complications after LT. The following spectral Doppler US parameters were measured before and after administration of USCA: peak systolic velocity, end-diastolic velocity, resistive index, and systolic acceleration time of the graft hepatic artery; peak flow velocity of the graft portal vein; and peak flow velocity and venous pulsatility index of the graft hepatic vein. Results: The mean peak systolic and end-diastolic velocities of the hepatic artery and the peak flow velocity of the portal and hepatic veins were increased after intravenously administration of the USCA, ranging from 10% to 13%. However, the changes were not statistically significant (P=0.097, 0.103, 0.128, and 0.190, respectively). There were no significant differences in other measured parameters, including the resistive index (P=0.205) and systolic acceleration time (P=0.489) of the hepatic artery and venous pulsatility index (P=0.494) of the hepatic vein. Conclusions: The measured velocities of graft hepatic vessels tended to increase after administration of USCA, but without statistical significance. The comparison of serial Doppler parameters with or without injection of USCA is valid during Doppler surveillance in recipients of LT.
참고문헌 (14)
- Jain A, "Long-term survival after liver transplantation in 4,000 consecutive patients at a single center", Ann Surg, 232, pp.490~500 (2000)
- Langnas AN, "Vascular complications after orthotopic liver transplantation", Am J Surg, 161, pp.76~82 (1991)
- Flint EW, "Duplex sonography of hepatic artery thrombosis after liver transplantation", AJR Am J Roentgenol, 151, pp.481~483 (1988)
- Dodd GD, "Hepatic artery stenosis and thrombosis in transplant recipients: Doppler diagnosis with resistive index and systolic acceleration time", Radiology, 192, pp.657~661 (1994)
- Herold C, "Contrast-enhanced ultrasound improves hepatic vessel visualization after orthotopic liver transplantation", Abdom Imaging, 26, pp.597~600 (2001)
- Shung KK, "Effect of flow disturbance on ultrasonic backscatter from blood", J Acoust Soc Am, 75, pp.1265~1272 (1984)
- Forsberg F, "Artifacts in ultrasonic contrast agent studies", J Ultrasound Med, 13, pp.357~365 (1994)
- Yokoyama N, "The effect of echo contrast agent on Doppler velocity measurements", Ultrasound Med Biol, 29, pp.765~770 (2003)
- Melany ML, "Effect of US contrast agents on spectral velocities: in vitro evaluation", Radiology, 211, pp.427~431 (1999)
- Gutberlet M, "Do ultrasonic contrast agents artificially increase maximum Doppler shift? In vivo study of human common carotid arteries", J Ultrasound Med, 17, pp.97~102 (1998)
- Heiken JP, "Dynamic contrast-enhanced CT of the liver: comparison of contrast medium injection rates and uniphasic and biphasic injection protocols", Radiology, 187, pp.327~331 (1993)
- Basilico R, "Reproducibility of Doppler ultrasonography in the study of hepatic blood flow", Radiol Med, 87, pp.268~274 (1994)
- Sacerdoti D, "Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirrhosis", J Hepatol, 27, pp.986~992 (1997)
- Hübner GH, "Hepatic arterial doppler sonography in patients with cirrhosis and controls: observer and equipment variability with use of the ultrasonic contrast agent SHU 508A", Z Gastroenterol, 43, pp.639~645 (2005)